Industry: Service & Software
Published Date: 2024-01-10
Pages: 148 Pages
Report ld: 3017928
Request Sample
Customized Report
The global market for Vaccine Management Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Vaccine Management Software was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vaccine Management Software was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Vaccine Management Software was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Vaccine Management Software include Intelex, Salesforce, ServiceNow, 1health, VaccineCheck, GaiaDigits, Microsoft Industry, VaxCare and Pomelo Health, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Vaccine Management Software, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Vaccine Management Software by region & country, by Type, and by Application.
The Vaccine Management Software market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Management Software.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vaccine Management Software manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Vaccine Management Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Vaccine Management Software in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Vaccine Management Software Product Introduction
1.2 Global Vaccine Management Software Market Size Forecast
1.3 Vaccine Management Software Market Trends & Drivers
1.3.1 Vaccine Management Software Industry Trends
1.3.2 Vaccine Management Software Market Drivers & Opportunity
1.3.3 Vaccine Management Software Market Challenges
1.3.4 Vaccine Management Software Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Vaccine Management Software Players Revenue Ranking (2023)
2.2 Global Vaccine Management Software Revenue by Company (2019-2024)
2.3 Key Companies Vaccine Management Software Manufacturing Base Distribution and Headquarters
2.4 Key Companies Vaccine Management Software Product Offered
2.5 Key Companies Time to Begin Mass Production of Vaccine Management Software
2.6 Vaccine Management Software Market Competitive Analysis
2.6.1 Vaccine Management Software Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Vaccine Management Software Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Management Software as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 On-premises
3.1.2 Cloud Based
3.2 Global Vaccine Management Software Sales Value by Type
3.2.1 Global Vaccine Management Software Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Vaccine Management Software Sales Value, by Type (2019-2030)
3.2.3 Global Vaccine Management Software Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital and Healthcare Facilities
4.1.2 Pharmacies and Retail Clinics
4.1.3 School
4.1.4 Workplace
4.1.5 Research and Development
4.1.6 Other
4.2 Global Vaccine Management Software Sales Value by Application
4.2.1 Global Vaccine Management Software Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Vaccine Management Software Sales Value, by Application (2019-2030)
4.2.3 Global Vaccine Management Software Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Vaccine Management Software Sales Value by Region
5.1.1 Global Vaccine Management Software Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Vaccine Management Software Sales Value by Region (2019-2024)
5.1.3 Global Vaccine Management Software Sales Value by Region (2025-2030)
5.1.4 Global Vaccine Management Software Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Vaccine Management Software Sales Value, 2019-2030
5.2.2 North America Vaccine Management Software Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Vaccine Management Software Sales Value, 2019-2030
5.3.2 Europe Vaccine Management Software Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Vaccine Management Software Sales Value, 2019-2030
5.4.2 Asia Pacific Vaccine Management Software Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Vaccine Management Software Sales Value, 2019-2030
5.5.2 South America Vaccine Management Software Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Vaccine Management Software Sales Value, 2019-2030
5.6.2 Middle East & Africa Vaccine Management Software Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Vaccine Management Software Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Vaccine Management Software Sales Value
6.3 United States
6.3.1 United States Vaccine Management Software Sales Value, 2019-2030
6.3.2 United States Vaccine Management Software Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Vaccine Management Software Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Vaccine Management Software Sales Value, 2019-2030
6.4.2 Europe Vaccine Management Software Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Vaccine Management Software Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Vaccine Management Software Sales Value, 2019-2030
6.5.2 China Vaccine Management Software Sales Value by Type (%), 2023 VS 2030
6.5.3 China Vaccine Management Software Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Vaccine Management Software Sales Value, 2019-2030
6.6.2 Japan Vaccine Management Software Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Vaccine Management Software Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Vaccine Management Software Sales Value, 2019-2030
6.7.2 South Korea Vaccine Management Software Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Vaccine Management Software Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Vaccine Management Software Sales Value, 2019-2030
6.8.2 Southeast Asia Vaccine Management Software Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Vaccine Management Software Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Vaccine Management Software Sales Value, 2019-2030
6.9.2 India Vaccine Management Software Sales Value by Type (%), 2023 VS 2030
6.9.3 India Vaccine Management Software Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Intelex
7.1.1 Intelex Profile
7.1.2 Intelex Main Business
7.1.3 Intelex Vaccine Management Software Products, Services and Solutions
7.1.4 Intelex Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.1.5 Intelex Recent Developments
7.2 Salesforce
7.2.1 Salesforce Profile
7.2.2 Salesforce Main Business
7.2.3 Salesforce Vaccine Management Software Products, Services and Solutions
7.2.4 Salesforce Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.2.5 Salesforce Recent Developments
7.3 ServiceNow
7.3.1 ServiceNow Profile
7.3.2 ServiceNow Main Business
7.3.3 ServiceNow Vaccine Management Software Products, Services and Solutions
7.3.4 ServiceNow Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.3.5 1health Recent Developments
7.4 1health
7.4.1 1health Profile
7.4.2 1health Main Business
7.4.3 1health Vaccine Management Software Products, Services and Solutions
7.4.4 1health Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.4.5 1health Recent Developments
7.5 VaccineCheck
7.5.1 VaccineCheck Profile
7.5.2 VaccineCheck Main Business
7.5.3 VaccineCheck Vaccine Management Software Products, Services and Solutions
7.5.4 VaccineCheck Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.5.5 VaccineCheck Recent Developments
7.6 GaiaDigits
7.6.1 GaiaDigits Profile
7.6.2 GaiaDigits Main Business
7.6.3 GaiaDigits Vaccine Management Software Products, Services and Solutions
7.6.4 GaiaDigits Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.6.5 GaiaDigits Recent Developments
7.7 Microsoft Industry
7.7.1 Microsoft Industry Profile
7.7.2 Microsoft Industry Main Business
7.7.3 Microsoft Industry Vaccine Management Software Products, Services and Solutions
7.7.4 Microsoft Industry Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.7.5 Microsoft Industry Recent Developments
7.8 VaxCare
7.8.1 VaxCare Profile
7.8.2 VaxCare Main Business
7.8.3 VaxCare Vaccine Management Software Products, Services and Solutions
7.8.4 VaxCare Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.8.5 VaxCare Recent Developments
7.9 Pomelo Health
7.9.1 Pomelo Health Profile
7.9.2 Pomelo Health Main Business
7.9.3 Pomelo Health Vaccine Management Software Products, Services and Solutions
7.9.4 Pomelo Health Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.9.5 Pomelo Health Recent Developments
7.10 LinkSafe
7.10.1 LinkSafe Profile
7.10.2 LinkSafe Main Business
7.10.3 LinkSafe Vaccine Management Software Products, Services and Solutions
7.10.4 LinkSafe Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.10.5 LinkSafe Recent Developments
7.11 Mazik Global
7.11.1 Mazik Global Profile
7.11.2 Mazik Global Main Business
7.11.3 Mazik Global Vaccine Management Software Products, Services and Solutions
7.11.4 Mazik Global Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.11.5 Mazik Global Recent Developments
7.12 Worksphere
7.12.1 Worksphere Profile
7.12.2 Worksphere Main Business
7.12.3 Worksphere Vaccine Management Software Products, Services and Solutions
7.12.4 Worksphere Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.12.5 Worksphere Recent Developments
7.13 ArbiMed
7.13.1 ArbiMed Profile
7.13.2 ArbiMed Main Business
7.13.3 ArbiMed Vaccine Management Software Products, Services and Solutions
7.13.4 ArbiMed Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.13.5 ArbiMed Recent Developments
7.14 Docpulse
7.14.1 Docpulse Profile
7.14.2 Docpulse Main Business
7.14.3 Docpulse Vaccine Management Software Products, Services and Solutions
7.14.4 Docpulse Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.14.5 Docpulse Recent Developments
7.15 Kainos
7.15.1 Kainos Profile
7.15.2 Kainos Main Business
7.15.3 Kainos Vaccine Management Software Products, Services and Solutions
7.15.4 Kainos Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.15.5 Kainos Recent Developments
7.16 GoCo
7.16.1 GoCo Profile
7.16.2 GoCo Main Business
7.16.3 GoCo Vaccine Management Software Products, Services and Solutions
7.16.4 GoCo Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.16.5 GoCo Recent Developments
7.17 Color Health
7.17.1 Color Health Profile
7.17.2 Color Health Main Business
7.17.3 Color Health Vaccine Management Software Products, Services and Solutions
7.17.4 Color Health Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.17.5 Color Health Recent Developments
7.18 Vax Central
7.18.1 Vax Central Profile
7.18.2 Vax Central Main Business
7.18.3 Vax Central Vaccine Management Software Products, Services and Solutions
7.18.4 Vax Central Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.18.5 Vax Central Recent Developments
7.19 Signetic
7.19.1 Signetic Profile
7.19.2 Signetic Main Business
7.19.3 Signetic Vaccine Management Software Products, Services and Solutions
7.19.4 Signetic Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.19.5 Signetic Recent Developments
7.20 Capterra
7.20.1 Capterra Profile
7.20.2 Capterra Main Business
7.20.3 Capterra Vaccine Management Software Products, Services and Solutions
7.20.4 Capterra Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.20.5 Capterra Recent Developments
7.21 Primary.Health
7.21.1 Primary.Health Profile
7.21.2 Primary.Health Main Business
7.21.3 Primary.Health Vaccine Management Software Products, Services and Solutions
7.21.4 Primary.Health Vaccine Management Software Revenue (US$ Million) & (2019-2024)
7.21.5 Primary.Health Recent Developments
8 Industry Chain Analysis
8.1 Vaccine Management Software Industrial Chain
8.2 Vaccine Management Software Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Vaccine Management Software Sales Model
8.5.2 Sales Channel
8.5.3 Vaccine Management Software Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Vaccine Management Software market size was US$ 316 million in 2025 and is forecast to reach a readjusted size of US$ 549 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 121
USD 4250.00
(Single User License)
The global market for Vaccine Management Software was estimated to be worth US$ 316 million in 2025 and is projected to reach US$ 549 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 180
USD 3950.00
(Single User License)
The global Vaccine Management Software market was valued at US$ 316 million in 2025 and is anticipated to reach US$ 549 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 175
USD 2900.00
(Single User License)
The global Vaccine Management Software market is projected to grow from US$ 291 million in 2024 to US$ 511 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 177
USD 4900.00
(Single User License)
The global Vaccine Management Software market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 511 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 121
USD 4250.00
(Single User License)
The global market for Vaccine Management Software was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 511 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published Date: 2025-08-07
Pages: 180
USD 3950.00
(Single User License)
The global market for Vaccine Management Software was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 511 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published Date: 2025-08-07
Pages: 114
USD 2900.00
(Single User License)
The global market for Vaccine Management Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 149
USD 3950.00
(Single User License)
Market Analysis and Insights: Global Vaccine Management Software Market
Published Date: 2024-04-12
Pages: 126
USD 4900.00
(Single User License)
The global Vaccine Management Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 103
USD 2900.00
(Single User License)
The global Vaccine Management Software market size was US$ 316 million in 2025 and is forecast to reach a readjusted size of US$ 549 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 121
The global market for Vaccine Management Software was estimated to be worth US$ 316 million in 2025 and is projected to reach US$ 549 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-03-06
Pages: 180
The global Vaccine Management Software market was valued at US$ 316 million in 2025 and is anticipated to reach US$ 549 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-03-06
Pages: 175
The global Vaccine Management Software market is projected to grow from US$ 291 million in 2024 to US$ 511 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 177
The global Vaccine Management Software market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 511 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 121
The global market for Vaccine Management Software was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 511 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-08-07
Pages: 180
The global market for Vaccine Management Software was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 511 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published: 2025-08-07
Pages: 114
The global market for Vaccine Management Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 149
Market Analysis and Insights: Global Vaccine Management Software Market
Published: 2024-04-12
Pages: 126
The global Vaccine Management Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now